ClinicalTrials.Veeva

Menu

Long-term Evaluation of a Nasopharyngeal Airway

University of Michigan logo

University of Michigan

Status

Enrolling

Conditions

Sleep Apnea, Obstructive

Treatments

Device: nasopharyngeal airway obstructive sleep apnea (NPA-OSA) device

Study type

Interventional

Funder types

Other

Identifiers

NCT07191314
HUM00274782

Details and patient eligibility

About

This long-term follow-up study will permit continued device use for participants of the parent study (NCT06677151).

During study participation the study team will stay in contact with participants as necessary. Additionally, patients will undergo clinical follow-up as needed with their physician(s). At 12 months, participants will complete sleep questionnaires as part of this long-term follow-up period.

Enrollment

20 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

-Participants who completed the parent study (HUM00179497) and wish to continue using the NPA-OSA device.

Exclusion criteria

  • The participants who were non-compliant with the NPA-OSA device during their participation in the parent study.

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

20 participants in 1 patient group

Nasopharyngeal airway device
Experimental group
Description:
A nasopharyngeal airway obstructive sleep apnea ("NPA"-OSA) device will be used for two years at home.
Treatment:
Device: nasopharyngeal airway obstructive sleep apnea (NPA-OSA) device

Trial contacts and locations

2

Loading...

Central trial contact

Louise M O'Brien, PhD; Zahra Nourmohammadi, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems